Wegovy – the brand name for semaglutide, the same compound that is in Ozempic – was launched for weight loss in the US in 2021 and quickly became so popular that the manufacturer, Novo Nordisk, could ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

One creator suggests that lemon balm helps with stress, insomnia, alertness, and that it’s been found to potentially help ...

Exploding sales of prescription weight loss medications have catapulted Novo Nordisk (NVO) and Eli Lilly (LLY) to become the ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

The Center for Human Nutrition at the U of A is conducting a research study to learn more about the effects of protein on ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

Analysts at JPMorgan Chase & Co. last week flagged that Novo Nordisk’s third-quarter results in November may show slower-than ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...